Privia Health Group Files 8-K on Shareholder Vote Matters

TL;DR

Privia Health had a shareholder vote on 5/21 - check the 8-K for details.

AI Summary

Privia Health Group, Inc. filed an 8-K on May 22, 2025, reporting on matters submitted to a vote of security holders on May 21, 2025. The filing details the company's corporate structure and its principal executive offices located at 950 N. Glebe Rd., Suite 700, Arlington, Virginia.

Why It Matters

This filing indicates a shareholder vote occurred, which could signal significant corporate decisions or changes impacting the company's direction and shareholder value.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not appear to contain any immediate negative financial or operational news.

Key Players & Entities

• Privia Health Group, Inc. (company) — Registrant
• May 21, 2025 (date) — Date of earliest event reported
• May 22, 2025 (date) — Date of Report
• 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (address) — Principal Executive Offices

FAQ

From the Filing

0001759655-25-000056.txt : 20250522 0001759655-25-000056.hdr.sgml : 20250522 20250522160341 ACCESSION NUMBER: 0001759655-25-000056 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250521 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250522 DATE AS OF CHANGE: 20250522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Privia Health Group, Inc. CENTRAL INDEX KEY: 0001759655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40365 FILM NUMBER: 25977012 BUSINESS ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-366-8850 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER COMPANY: FORMER CONFORMED NAME: PH Group Parent Corp. DATE OF NAME CHANGE: 20181120 8-K 1 prva-20250521.htm 8-K prva-20250521 0001759655 FALSE 0001759655 2025-05-21 2025-05-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K _______________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2025 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (Address of Principal Executive Offices) (Zip Code) ( 571 ) 366-8850 Registrant's telephone number, including area code Not Applicable (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07 Submission of Matters to a Vote of Security Holders On May 21, 2025, Privia Health Group, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) via live webcast. At the Annual Meeting, the Company’s stockholders approved all three proposals. Proposal No. 1: Election of directors. The following three nominees were elected to serve as Class III directors for a term expiring at the Company’s 2028 Annual Meeting of Stockholders, or until such director's respective successor is duly elected and qualified or such director's earlier death, resignation or removal. Nominee Votes For Votes Wit